Eine vollständige Bewerbung in einer Minute
Maßgeschneiderter Lebenslauf und Anschreiben – versandbereit.
Genentech, a member of the Roche group, is seeking a Scientist 3 in Translational Oncology for a lab-based role in South San Francisco. You will be the flow cytometry expert, designing and executing high-parameter panels to profile immune and cancer biology targets.
You will work with primary cells and established cell lines, analyze complex data, and partner with cross-functional teams to translate discovery findings into potential therapies.
Join our Translational Oncology department as a Scientist 3, where your technical precision and deep immunological expertise will bridge the gap between early discovery and life-changing clinical therapies. In this pivotal, lab-based role, you will serve as our go-to flow cytometry expert, thriving in a collaborative, fast-paced environment that empowers bold scientific inquiry.
This is a lab-based role at our South San Francisco, CA campus. Onsite presence is required. Relocation benefits are not available for this job posting.
The expected salary range for this position based on the primary location of South San Francisco, CA is $103,400 - $192,000. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. This position also qualifies for the benefits detailed at the link provided below.
Genentech, a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life‑threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. The next step is yours.